Istradefylline
- Generic Name
- Istradefylline
- Brand Names
- Nourianz
- Drug Type
- Small Molecule
- Chemical Formula
- C20H24N4O4
- CAS Number
- 155270-99-8
- Unique Ingredient Identifier
- 2GZ0LIK7T4
- Background
Istradefylline, or KW6002, was developed by Kyowa Hakko Kirin in Japan for the treatment of Parkinson's disease as an adjunct to standard therapy. Unlike standard dopaminergic therapies for Parkinson's, Istradefylline targets adenosine A receptors in the basal ganglia. This region of the brain is highly involved in motor control.
...
- Indication
Istradefylline is indicated in adjunct to levodopa and carbidopa in the treatment of Parkinson's disease.
- Associated Conditions
- Parkinson's Disease (PD)
- Associated Therapies
- -
No news found
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath